Safety and Immunogenicity of CYT004-MelQbG10 Vaccine With and Without Adjuvant in Advanced Stage Melanoma Patients
The purpose of this study is to evaluate a specific cellular immune response in melanoma patients that have been vaccinated with a Melan-A VLP vaccine alone or in combination with different adjuvants.
Malignant Melanoma
BIOLOGICAL: CYT004-MelQbG10 + Montanide|BIOLOGICAL: CYT004-MelQbG10 + Montanide + Imiquimod|BIOLOGICAL: CYT004-MelQbG10 + Imiquimod|BIOLOGICAL: CYT004-MelQbG10 intra nodal injection
The purpose of this study is to evaluate a specific cellular immune response in melanoma patients that have been vaccinated with a Melan-A VLP vaccine alone or in combination with different adjuvants.